TP53 and prostate adenocarcinoma: The TP53 pathway was correlated with ATM overexpression in PRAD (R = 0.80, FDR = 7.8e − 15) and CHEK2 overexpression in STAD (R = 0.57, FDR = 7.4e − 6).